Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 64
Filtrar
1.
Clin Nephrol ; 91(1): 40-47, 2019 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-30369398

RESUMO

Variants in apolipoprotein L1 (APOL1) gene were shown to be associated with higher rates of nondiabetic kidney disease in black patients compared with white patients. Frequencies of these variants differ substantially in African populations, suggesting that their contribution to kidney disease might differ. We determined the frequency and association of (APOL1) risk alleles with markers of kidney disease in black South Africans with hypertension-attributed chronic kidney disease (CKD) and their first-degree relatives. Black patients with hypertension-attributed CKD with an estimated glomerular filtration rate (eGFR) ≤ 60 mL/min/1.73m2 were included, together with their first-degree relatives. G1 (rs60910145 and rs73885319) and G2: rs71785313 single nucleotide polymorphisms were genotyped by restriction fragment length polymorphism. Similar to previous association studies, we mainly tested recessive genetic models. The allele frequencies of both the G1 and G2 (APOL1) risk alleles were similar amongst all the groups. There was no difference in the two-risk-allele frequency in CKD patients (10%) compared to controls (8.6%), p = 0.790. Carriage of two (APOL1) risk alleles (vs. zero or one risk allele) was not a predictor of hypertension-attributed CKD (OR, 0.85; 95% CI, 0.25 - 2.83; p = 0.790). Patients with CKD and first-degree relatives with and without (APOL1) risk alleles had statistically indistinguishable blood pressures, creatinine and HDL-cholesterol levels. Apolipoprotein L1 risk variants are present in black South Africans with similar frequencies between CKD patients, first-degree relatives, and healthy controls. The lack of association of these variants with hypertension-attributed CKD in this population needs to be explored further in studies with larger sample sizes.
.


Assuntos
Apolipoproteína L1/genética , Hipertensão Renal/genética , Nefrite/genética , Insuficiência Renal Crônica/genética , Adulto , Alelos , População Negra/genética , Estudos de Casos e Controles , Creatinina/sangue , Feminino , Frequência do Gene , Predisposição Genética para Doença , Variação Genética , Genótipo , Taxa de Filtração Glomerular , Humanos , Hipertensão Renal/etnologia , Lipídeos/sangue , Masculino , Pessoa de Meia-Idade , Nefrite/etnologia , Polimorfismo de Nucleotídeo Único , Prevalência , Insuficiência Renal Crônica/etnologia , Insuficiência Renal Crônica/etiologia , Fatores de Risco , Adulto Jovem
3.
Nephrol Dial Transplant ; 30(8): 1329-35, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-25817226

RESUMO

BACKGROUND: Anemia is common in chronic kidney disease (CKD) and associated with poor outcomes. In cross-sectional studies, lower estimated glomerular filtration rate (eGFR) has been associated with increased risk for anemia. The aim of this study was to determine how hematocrit changes as eGFR declines and what factors impact this longitudinal association. METHODS: We followed 1094 African-Americans with hypertensive nephropathy who participated in the African-American Study of Kidney Disease and Hypertension. Mixed effects models were used to determine longitudinal change in hematocrit as a function of eGFR. Interaction terms were used to assess for differential effects of age, gender, baseline eGFR, baseline proteinuria, malnutrition and inflammation on eGFR-associated declines in hematocrit. In sensitivity analyses, models were run using iGFR (by renal clearance of I(125) iothalamate) in place of eGFR. RESULTS: At baseline, mean hematocrit was 39% and 441 (40%) individuals had anemia. The longitudinal relationship between eGFR and hematocrit differed by baseline eGFR and was steeper when baseline eGFR was <45 mL/min/1.73 m(2). For example, the absolute decline in hematocrit per 10 mL/min/1.73 m(2) decline in longitudinal eGFR was -3.7, -1.3 and -0.5% for baseline eGFR values of 20, 40 and 60 mL/min/1.73 m(2), respectively (P < 0.001 comparing the longitudinal association between baseline eGFR = 40 or 60 versus baseline eGFR = 20 mL/min/1.73 m(2)). Similarly, male sex, younger age (<65 years) and higher baseline proteinuria (protein-to-creatinine ratio >0.22) were associated with greater hematocrit declines per unit decrease in longitudinal eGFR compared with female sex, older age and low baseline proteinuria, respectively (P-interaction <0.05 for each comparison). The longitudinal eGFR-hematocrit association did not differ by body mass index, serum albumin or C-reactive protein. CONCLUSIONS: Men, younger individuals and those with low baseline eGFR (<45 mL/min/1.73 m(2)) or baseline proteinuria are particularly at risk for eGFR-related declines in hematocrit.


Assuntos
Anemia/diagnóstico , Negro ou Afro-Americano/estatística & dados numéricos , Taxa de Filtração Glomerular , Hematócrito , Hipertensão Renal/complicações , Hipertensão/fisiopatologia , Ácido Iotalâmico/metabolismo , Nefrite/complicações , Adolescente , Adulto , Idoso , Anemia/etiologia , Anemia/metabolismo , Índice de Massa Corporal , Proteína C-Reativa , Estudos Transversais , Feminino , Humanos , Hipertensão/etnologia , Hipertensão Renal/etnologia , Hipertensão Renal/patologia , Testes de Função Renal , Estudos Longitudinais , Masculino , Pessoa de Meia-Idade , Nefrite/etnologia , Nefrite/patologia , Proteinúria/sangue , Proteinúria/etiologia , Insuficiência Renal Crônica/complicações , Insuficiência Renal Crônica/patologia , Estados Unidos , Adulto Jovem
4.
Nephrol Dial Transplant ; 29(7): 1399-409, 2014 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-24327566

RESUMO

BACKGROUND: African Americans have more severe hypertensive nephrosclerosis than white Americans, possibly at similar levels of blood pressure. Glomerular volume is increased in African Americans relative to whites, but it is uncertain how this relates to nephrosclerosis and whether it contributes to or compensates for glomerulosclerosis. METHODS: Stereological disector/fractionator estimates of glomerular number (N(glom)) and average glomerular volume (V(glom)) were obtained on autopsy kidneys of 171 African Americans and 131 whites. Eighty-eight African Americans and 49 whites were identified as hypertensive. Nephrosclerosis was measured morphometrically as the percentage of glomerulosclerosis, proportion of cortical fibrosis and interlobular artery intimal thickness, and analyzed with V(glom) by age, race, gender, body mass index (BMI) and blood pressure. RESULTS: African Americans were more frequently hypertensive (58.5%) than whites (35.8%) and when hypertensive had higher levels of blood pressure (P = 0.02). N(glom) was significantly lower in hypertensive compared with non-hypertensive subjects among white women (P = 0.02) but not white males (P = 0.34) or African American females (P = 0.10) or males (P = 0.41). For each race and gender, glomerulosclerosis, cortical fibrosis and arterial intimal thickening were statistically correlated with age (P < 0.001) and hypertension (P < 0.001) and increased V(glom) with hypertension (P < 0.001) and BMI (P < 0.001). In multivariate analysis, African American race was associated with increased V(glom) (P = 0.01) and arterial intimal thickening (P < 0.01), while interactions between race and blood pressure indicated that the severity of nephrosclerosis including increased V(glom) was linked most directly to hypertension without significant contributions from race. The hypertension-associated enlargement of V(glom) was present with mild degrees of glomerulosclerosis and changed little as the severity of glomerulosclerosis increased. CONCLUSIONS: Glomerular hypertrophy was identified as an integral feature of hypertensive nephropathy and appeared to precede rather than compensate for glomerulosclerosis. An effect of race on V(glom) and arterial intimal thickening seemed to be related to the more frequent and more severe hypertension among African Americans.


Assuntos
Negro ou Afro-Americano/estatística & dados numéricos , Hipertensão Renal/etnologia , Hipertensão/etnologia , Glomérulos Renais/patologia , Nefrite/etnologia , Nefroesclerose/etnologia , População Branca/estatística & dados numéricos , Adolescente , Adulto , Fatores Etários , Idoso , Idoso de 80 Anos ou mais , Arteriosclerose/etnologia , Arteriosclerose/patologia , Autopsia , Pressão Sanguínea , Criança , Pré-Escolar , Feminino , Fibrose/etnologia , Fibrose/patologia , Taxa de Filtração Glomerular , Humanos , Hipertensão/patologia , Hipertensão Renal/patologia , Hipertrofia/etnologia , Hipertrofia/patologia , Lactente , Recém-Nascido , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Nefrite/patologia , Nefroesclerose/patologia , Prognóstico , Adulto Jovem
5.
Hypertension ; 63(2): 297-302, 2014 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-24218434

RESUMO

A soluble (pro)renin receptor (sPRR) circulates in plasma and is able to bind renin and prorenin. It is not known whether plasma sPRR concentrations vary with the activity of the renin-angiotensin system. We measured plasma sPRR, renin, prorenin, and aldosterone concentrations in 121 white and 9 black healthy subjects, 40 patients with diabetes mellitus, 41 hypertensive patients with or without renin-angiotensin system blockers, 9 patients with primary aldosteronism, and 10 patients with Gitelman syndrome. Median physiological plasma sPRR concentration was 23.5 ng/mL (interquartile range, 20.9-26.5) under usual uncontrolled sodium diet. sPRR concentration in healthy subjects, unlike renin and prorenin, did not display circadian variation or dependence on age, sex, posture, or hormonal status. sPRR concentrations were ≈25% lower in black than in white subjects, whereas renin concentrations were ≈40% lower. Patients with diabetes mellitus (average renin-high prorenin levels) and with hypertension only (average renin-average prorenin levels) had sPRR concentrations similar to healthy subjects. Renin-angiotensin system blockade was associated with increase of sPRR concentration by ≈12%. sPRR in patients with primary aldosteronism (low renin-low prorenin) and Gitelman syndrome (high renin-high prorenin) were similar and ≈10% higher than in healthy subjects. There was no correlation between sPRR and renin or prorenin. In conclusion, our results show that plasma sPRR concentrations are dependent on ethnicity and independent of renin, prorenin, and aldosterone concentrations in healthy subjects and in patients with contrasted degrees of renin-angiotensin system activity.


Assuntos
Aldosterona/sangue , Nefropatias Diabéticas/etnologia , Hipertensão Renal/etnologia , Receptores de Superfície Celular/sangue , Renina/sangue , ATPases Vacuolares Próton-Translocadoras/sangue , Adolescente , Adulto , Idoso , População Negra/estatística & dados numéricos , Diabetes Mellitus Tipo 1/sangue , Diabetes Mellitus Tipo 1/etnologia , Diabetes Mellitus Tipo 2/sangue , Diabetes Mellitus Tipo 2/etnologia , Nefropatias Diabéticas/sangue , Feminino , Síndrome de Gitelman/sangue , Síndrome de Gitelman/etnologia , Humanos , Hiperaldosteronismo/sangue , Hiperaldosteronismo/etnologia , Hipertensão Renal/sangue , Masculino , Pessoa de Meia-Idade , Projetos Piloto , Sistema Renina-Angiotensina/fisiologia , Solubilidade , População Branca/estatística & dados numéricos , Adulto Jovem
6.
Curr Opin Nephrol Hypertens ; 22(3): 266-72, 2013 May.
Artigo em Inglês | MEDLINE | ID: mdl-23470819

RESUMO

PURPOSE OF REVIEW: Hypertension is the attributed cause of approximately 30% of end-stage kidney disease cases in the United States, but there has been controversy as to whether benign hypertension is a cause of chronic kidney disease. RECENT FINDINGS: The histology of chronic kidney disease attributed to nonmalignant hypertension is arterionephrosclerosis, with pathology in the terminal branches of the interlobular arteries, together with global glomerulosclerosis. The identification of coding region variants in APOL1, encoding apolipoprotein L1, has opened a new perspective on this debate. These variants are restricted to populations of recent African descent and are strongly associated with clinically diagnosed arterionephrosclerosis, particularly when there is moderate-grade or high-grade proteinuria or progression to more advanced levels of kidney dysfunction. Nevertheless, not all African Americans with hypertension who progress to end-stage kidney disease have two APOL1 risk variants, and individuals of European and Asian descent also manifest arterionephrosclerosis. Further, we do not understand the mechanisms by which APOL1 initiates pathology in the renal microcirculation. SUMMARY: APOL1 nephropathy comprises a disease spectrum (perhaps with distinct endophenotypes), including focal segmental glomerulosclerosis, collapsing glomerulopathy, and arterionephrosclerosis. The terms hypertensive kidney disease and hypertensive nephrosclerosis have outlived their usefulness. It may be time to use the established, etiologically neutral term, arterionephrosclerosis, to consider whether this is a disease rather than a pathologic description, and to determine the causal role of various clinical correlates including aging, obesity, hyperlipidemia, smoking, chronic inflammation, and oxidative stress.


Assuntos
Apolipoproteínas/genética , Metabolismo Energético , Variação Genética , Hipertensão Renal/etiologia , Mediadores da Inflamação/metabolismo , Lipoproteínas HDL/genética , Nefrite/etiologia , Estresse Oxidativo , Insuficiência Renal Crônica/etiologia , Animais , Apolipoproteína L1 , Comorbidade , Progressão da Doença , Predisposição Genética para Doença , Humanos , Hipertensão Renal/etnologia , Hipertensão Renal/genética , Hipertensão Renal/imunologia , Hipertensão Renal/metabolismo , Nefrite/etnologia , Nefrite/genética , Nefrite/imunologia , Nefrite/metabolismo , Fenótipo , Prognóstico , Grupos Raciais/genética , Insuficiência Renal Crônica/etnologia , Insuficiência Renal Crônica/genética , Insuficiência Renal Crônica/imunologia , Insuficiência Renal Crônica/metabolismo , Fatores de Risco
7.
Kidney Int ; 83(1): 6-9, 2013 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-23271482

RESUMO

Lipkowitz et al. extend the African American Study of Kidney Disease and Hypertension to the level of genetic epidemiology, in a case-control study design. Analysis of genotypes at the APOL1 kidney disease risk region supports a paradigm shift in which genetic risk is proximate to both kidney disease and hypertension. The findings mandate urgency in clarifying mechanisms whereby APOL1 region risk variants interact with environmental triggers to cause progressive kidney disease accompanied by dangerous hypertension.


Assuntos
Apolipoproteínas/genética , Negro ou Afro-Americano/etnologia , Negro ou Afro-Americano/genética , Variação Genética/genética , Hipertensão Renal/etnologia , Hipertensão Renal/genética , Rim/fisiopatologia , Lipoproteínas HDL/genética , Nefrite/etnologia , Nefrite/genética , Apolipoproteína L1 , Feminino , Humanos , Masculino
8.
Clin J Am Soc Nephrol ; 8(1): 75-81, 2013 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-23085727

RESUMO

BACKGROUND AND OBJECTIVES: The African American Study of Kidney Disease Trial identified risk factors for CKD progression and suggested that GFR level may modify the association between these risk factors and CKD progression or death. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Enrollment in the African American Study of Kidney Disease Trial occurred between June of 1995 and September of 2001, with median follow-up of 48.6 months. Among 1094 patients with hypertensive kidney disease in the trial, this study tested whether the association between six previously identified risk factors for CKD progression (or death) and a composite clinical outcome (progression of CKD, ESRD, or death) depends on level of GFR. Multivariate Cox regression was used to control for other baseline risk factors. RESULTS: After controlling for baseline risk factors, only proteinuria was more closely associated with the composite clinical outcome at lower levels of GFR (P value for interaction term=0.002); increased hazards of the clinical composite outcome associated with a doubling of proteinuria ranged from 30% (95% confidence interval=21%-39%) with a GFR of 50 to 55% (95% confidence interval=40%-72%) with a GFR of 25. CONCLUSIONS: The magnitude of the association between proteinuria and CKD progression, ESRD, or death in the African American Study of Kidney Disease Trial cohort depends on the level of GFR; proteinuria is a stronger independent predictor of the composite clinical outcome at lower levels of GFR. This finding reinforces that African Americans with proteinuria and lower GFR represent a population at particularly high risk for adverse outcomes.


Assuntos
Negro ou Afro-Americano/estatística & dados numéricos , Taxa de Filtração Glomerular , Insuficiência Renal Crônica/etnologia , Insuficiência Renal Crônica/mortalidade , Adulto , Idoso , Progressão da Doença , Feminino , Seguimentos , Humanos , Hipertensão Renal/etnologia , Hipertensão Renal/mortalidade , Estimativa de Kaplan-Meier , Falência Renal Crônica/etnologia , Falência Renal Crônica/mortalidade , Masculino , Pessoa de Meia-Idade , Morbidade , Análise Multivariada , Proteinúria/etnologia , Proteinúria/mortalidade , Fatores de Risco , Estados Unidos/epidemiologia
9.
Am J Physiol Renal Physiol ; 304(4): F348-55, 2013 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-23220723

RESUMO

Oxidative stress is acknowledged to play a role in kidney disease progression. Genetic variants that affect the capacity to handle oxidative stress may therefore influence the outcome of kidney disease. We examined whether genetic variants of the GSTM1 gene, a member of a superfamily of glutathione S-transferases, influence the course of kidney disease progression in participants of the African American Study of Kidney Disease (AASK) trial. Groups with and without the common GSTM1 null allele, GSTM1(0), differed significantly in the time to a glomerular filtration rate (GFR) event or dialysis (P = 0.04) and in the time to GFR event, dialysis, or death (P = 0.02). The hazard ratios (HR) for the time to a GFR event or dialysis in those with two or one null allele relative to those possessing none were 1.88 [95% confidence interval (CI), 1.07 to 3.30, P = 0.03] and 1.68 (95% CI, 1.00 to 2.84, P < 0.05), respectively. For the time to GFR event, dialysis, or death, the HR for two null alleles was 2.06 (95% CI, 1.20 to 3.55, P = 0.01) and for one null allele 1.70 (95% CI, 1.02 to 2.81, P = 0.04). We demonstrated that GSTM1 directly regulates intracellular levels of 4-hydroxynonenal (4-HNE) in vascular smooth muscle cells. Furthermore, we showed that renal 4-HNE levels and GSTM1 are both increased after reduction of renal mass (RRM) in the mouse. We conclude that GSTM1 is normally upregulated in chronic kidney disease (CKD) in a protective response to increased oxidative stress. A genetic variant that results in loss of GSTM1 activity may be deleterious in CKD.


Assuntos
Glutationa Transferase/genética , Glutationa Transferase/fisiologia , Hipertensão Renal/etnologia , Hipertensão Renal/genética , Nefrite/etnologia , Nefrite/genética , Aldeídos/metabolismo , Animais , População Negra/genética , População Negra/estatística & dados numéricos , Células Cultivadas , Progressão da Doença , Feminino , Inativação Gênica/fisiologia , Taxa de Filtração Glomerular/genética , Taxa de Filtração Glomerular/fisiologia , Humanos , Hipertensão Renal/enzimologia , Hipertensão Renal/mortalidade , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Pessoa de Meia-Idade , Músculo Liso Vascular/fisiologia , Miócitos de Músculo Liso/fisiologia , Fator 2 Relacionado a NF-E2/fisiologia , Nefrite/enzimologia , Nefrite/mortalidade , Estresse Oxidativo/genética , Estresse Oxidativo/fisiologia , Ensaios Clínicos Controlados Aleatórios como Assunto , Insuficiência Renal Crônica/enzimologia , Insuficiência Renal Crônica/genética , Insuficiência Renal Crônica/fisiopatologia
10.
Kidney Int ; 83(1): 114-20, 2013 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-22832513

RESUMO

Despite intensive antihypertensive therapy there was a high incidence of renal end points in participants of the African American Study of Kidney Disease and Hypertension (AASK) cohort. To better understand this, coding variants in the apolipoprotein L1 (APOL1) and the nonmuscle myosin heavy chain 9 (MYH9) genes were evaluated for an association with hypertension-attributed nephropathy and clinical outcomes in a case-control study. Clinical data and DNA were available for 675 AASK participant cases and 618 African American non-nephropathy control individuals. APOL1 G1 and G2, and MYH9 E1 variants along with 44 ancestry informative markers, were genotyped with allele frequency differences between cases and controls analyzed by logistic regression multivariable models adjusting for ancestry, age, and gender. In recessive models, APOL1 risk variants were significantly associated with kidney disease in all cases compared to controls with an odds ratio of 2.57. In AASK cases with more advanced disease, such as a baseline urine protein to creatinine ratio over 0.6 g/g or a serum creatinine over 3 mg/dl during follow-up, the association was strengthened with odds ratios of 6.29 and 4.61, respectively. APOL1 risk variants were consistently associated with renal disease progression across medication classes and blood pressure targets. Thus, kidney disease in AASK participants was strongly associated with APOL1 renal risk variants.


Assuntos
Apolipoproteínas/genética , Negro ou Afro-Americano/etnologia , Negro ou Afro-Americano/genética , Variação Genética/genética , Hipertensão Renal/etnologia , Hipertensão Renal/genética , Rim/fisiopatologia , Lipoproteínas HDL/genética , Nefrite/etnologia , Nefrite/genética , Adulto , Idoso , Anti-Hipertensivos/farmacologia , Anti-Hipertensivos/uso terapêutico , Apolipoproteína L1 , Pressão Sanguínea/efeitos dos fármacos , Pressão Sanguínea/fisiologia , Estudos de Casos e Controles , Creatinina/sangue , Feminino , Frequência do Gene/genética , Taxa de Filtração Glomerular/efeitos dos fármacos , Taxa de Filtração Glomerular/fisiologia , Humanos , Hipertensão Renal/tratamento farmacológico , Masculino , Pessoa de Meia-Idade , Proteínas Motores Moleculares/genética , Cadeias Pesadas de Miosina/genética , Nefrite/tratamento farmacológico , Fatores de Risco , Fatores de Tempo , Resultado do Tratamento
12.
J Am Soc Nephrol ; 23(4): 706-13, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-22402803

RESUMO

The typical assumption is that patients with CKD will have progressive nephropathy. Methodological issues, such as measurement error and regression to the mean, have made it difficult to document whether kidney function might improve in some patients. Here, we used data from 12 years of follow-up in the African American Study of Kidney Disease and Hypertension to determine whether some patients with CKD can experience a sustained improvement in GFR. We calculated estimated GFR (eGFR) based on serum creatinine measurements during both the trial and cohort phases. We defined clearly improved patients as those with positive eGFR slopes that we could not explain by random measurement variation under Bayesian mixed-effects models. Of 949 patients with at least three follow-up eGFR measurements, 31 (3.3%) demonstrated clearly positive eGFR slopes. The mean slope among these patients was +1.06 (0.12) ml/min per 1.73 m(2) per yr, compared with -2.45 (0.07) ml/min per 1.73 m(2) per yr among the remaining patients. During the trial phase, 24 (77%) of these 31 patients also had clearly positive slopes of (125)I-iothalamate-measured GFR during the trial phase. Low levels of proteinuria at baseline and randomization to the lower BP goal (mean arterial pressure ≤92 mmHg) associated with improved eGFR. In conclusion, the extended follow-up from this study provides strong evidence that kidney function can improve in some patients with hypertensive CKD.


Assuntos
Creatinina/sangue , Taxa de Filtração Glomerular/fisiologia , Hipertensão Renal/diagnóstico , Falência Renal Crônica/diagnóstico , Adolescente , Adulto , Negro ou Afro-Americano/estatística & dados numéricos , Idoso , Anti-Hipertensivos/uso terapêutico , Teorema de Bayes , Feminino , Seguimentos , Humanos , Hipertensão Renal/tratamento farmacológico , Hipertensão Renal/etnologia , Falência Renal Crônica/etnologia , Testes de Função Renal , Masculino , Pessoa de Meia-Idade , Valores de Referência , Medição de Risco , Índice de Gravidade de Doença , Fatores de Tempo , Adulto Jovem
13.
J Am Soc Hypertens ; 6(3): 193-200, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22341790

RESUMO

Although electrocardiographic criteria for diagnosing left ventricular hypertrophy have a low sensitivity in the general population, their test characteristics have not been evaluated in the high-prevalence group of American Americans with chronic kidney disease. The purpose of the current study was to evaluate these test characteristics among African Americans (n = 645) with hypertensive kidney disease as part of the African-American Study of Kidney Disease and Hypertension cohort. Electrocardiograms were read by 2 cardiologists at an independent core laboratory using the 2 Sokolow-Lyon criteria and the Cornell criteria. Left ventricular hypertrophy on echocardiography was defined as left ventricular mass index greater than 49.2 and greater than 46.7 g/m(2.7) in men and women, respectively. Sixty-nine percent of the population had left ventricular hypertrophy on echo, whereas 34% had left ventricular hypertrophy by any of the electrocardiographic criteria. Sensitivity by individual electrocardiographic criteria was 16.5% by Sokolow-Lyon-1, 19.3% by Sokolow-Lyon-2, and 24.7% by Cornell criteria, with specificity ranging from 89% to 92%. When using any of the 3 criteria, sensitivity increased to 40.4% with a decrease in specificity to 78.0%. Consistent with findings in a general population, left ventricular hypertrophy by electrocardiography had low sensitivity and high specificity in this cohort of African Americans with hypertensive kidney disease.


Assuntos
Negro ou Afro-Americano , Ecocardiografia/métodos , Eletrocardiografia/métodos , Hipertensão Renal/complicações , Hipertrofia Ventricular Esquerda/diagnóstico , Falência Renal Crônica/etnologia , Antagonistas Adrenérgicos beta/uso terapêutico , Inibidores da Enzima Conversora de Angiotensina/uso terapêutico , Bloqueadores dos Canais de Cálcio/uso terapêutico , Progressão da Doença , Quimioterapia Combinada , Feminino , Seguimentos , Humanos , Hipertensão Renal/tratamento farmacológico , Hipertensão Renal/etnologia , Hipertrofia Ventricular Esquerda/etnologia , Hipertrofia Ventricular Esquerda/etiologia , Incidência , Falência Renal Crônica/complicações , Falência Renal Crônica/diagnóstico , Masculino , Pessoa de Meia-Idade , Prevalência , Estudos Prospectivos , Curva ROC , Reprodutibilidade dos Testes , Estados Unidos/epidemiologia
14.
Nephrol Dial Transplant ; 27(1): 197-205, 2012 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-21613384

RESUMO

BACKGROUND: Hyperhomocysteinemia is associated with increased venous thrombosis and cardiovascular disease (CVD). Mutations in the human methylenetetrahydrofolate reductase (MTHFR) gene have been associated with increased homocysteine levels and risks of CVD in various populations including those with kidney disease. Here, we evaluated the influence of MTHFR variants on progressive loss of kidney function. METHODS: We analyzed 821 subjects with hypertensive nephrosclerosis from the longitudinal National Institute of Diabetes and Digestive and Kidney Diseases African-American Study of Kidney Disease and Hypertension (AASK) Trial to determine whether decline in glomerular filtration rate (GFR) over ∼4.2 years was predicted by common genetic variation within MTHFR at non-synonymous positions C677T (Ala222Val) and A1298C (Glu429Ala) or by MTHFR haplotypes. The effect on GFR decline was then supported by a study of 1333 subjects from the San Diego Veterans Affairs Hypertension Cohort (VAHC), followed over ∼4.5 years. Linear effect models were utilized to determine both genotype [single-nucleotide polymorphism (SNP)] and genotype (SNP)-by-time interactions. RESULTS: In AASK, the polymorphism at A1298C predicted the rate of GFR decline: A1298/A1298 major allele homozygosity resulted in a less pronounced decline of GFR, with a significant SNP-by-time interaction. An independent follow-up study in the San Diego VAHC subjects supports that A1298/A1298 homozygotes have the greatest estimated GFR throughout the study. Haplotype analysis with C677T yielded concurring results. CONCLUSION: We conclude that the MTHFR-coding polymorphism at A1298C is associated with renal decline in African-Americans with hypertensive nephrosclerosis and is supported by a veteran cohort with a primary care diagnosis of hypertension. Further investigation is needed to confirm such findings and to determine what molecular mechanism may contribute to this association.


Assuntos
Biomarcadores/metabolismo , Hipertensão Renal/complicações , Falência Renal Crônica/etiologia , Metilenotetra-Hidrofolato Redutase (NADPH2)/genética , Nefroesclerose/etiologia , Polimorfismo de Nucleotídeo Único/genética , Adolescente , Adulto , Idoso , DNA/genética , Feminino , Seguimentos , Taxa de Filtração Glomerular , Haplótipos/genética , Humanos , Hipertensão Renal/etnologia , Hipertensão Renal/genética , Falência Renal Crônica/etnologia , Testes de Função Renal , Estudos Longitudinais , Masculino , Pessoa de Meia-Idade , Nefroesclerose/etnologia , Reação em Cadeia da Polimerase , Prognóstico , Fatores de Risco , Fatores de Tempo , Adulto Jovem
15.
Hypertension ; 59(1): 62-9, 2012 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-22146509

RESUMO

In high-Na(+), low-K(+) diets, which suppress renin release in salt-sensitive groups, the mechanisms maintaining increases in renin-angiotensin-aldosterone system activation downstream from renin and renin-angiotensin-aldosterone system-induced effects on blood pressure (BP) are uncertain. Whether circulating angiotensinogen concentrations (AGT) or its determinants may contribute to maintaining serum aldosterone concentrations (aldosterone) and increases in BP on high-Na(+), low-K(+) diets was evaluated in 579 participants of a community sample of African ancestry. Plasma renin concentrations were inversely related to BP (P<0.0001) and an index of salt intake (24-hour urinary Na(+)/K(+), P<0.0001). An interaction between AGT and urinary Na(+)/K(+) was independently associated with aldosterone (P<0.001) and systolic BP (SBP; P<0.05). Independent of confounders, in participants with urinary Na(+)/K(+) at or more than the median for the sample, AGT was positively associated with aldosterone (P<0.0001) and SBP (P<0.005). No independent AGT-aldosterone or AGT-SBP relationships were noted in participants with urinary Na(+)/K(+) less than the median for the sample. Standardized ß-coefficients (slopes) of AGT-aldosterone and AGT-SBP relationships were greater in participants with urinary Na(+)/K(+) at or more than the median (AGT-aldosterone=0.30±0.06, AGT-SBP=0.16±0.05) compared with those with urinary Na(+)/K(+) less than the median (AGT-aldosterone=-0.04±0.06; AGT-SBP=-0.03±0.05; P<0.01-0.0001 for comparison of slopes). The AGT-SBP relationship in participants with urinary Na(+)/K(+) at or more than the median for the sample was equivalent to the relationship between body mass index and BP. In conclusion, in participants of African ancestry, in the presence of high-Na(+), low-K(+) diets, which suppress renin release, renin-angiotensin-aldosterone system activation and its impact on BP are maintained in part by AGT.


Assuntos
Aldosterona/sangue , Angiotensinogênio/sangue , Negro ou Afro-Americano/estatística & dados numéricos , Pressão Sanguínea/fisiologia , Hipertensão Renal/etnologia , Hipertensão Renal/metabolismo , Cloreto de Sódio na Dieta/administração & dosagem , Adulto , Angiotensinogênio/genética , Proteína C-Reativa/metabolismo , Creatinina/urina , Feminino , Genótipo , Humanos , Hipertensão Renal/genética , Masculino , Pessoa de Meia-Idade , Potássio na Dieta/administração & dosagem , Potássio na Dieta/urina , Renina/sangue , Sistema Renina-Angiotensina/fisiologia , Fatores de Risco , Cloreto de Sódio na Dieta/urina , Adulto Jovem
18.
Cardiology ; 120(3): 125-9, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-22179118

RESUMO

BACKGROUND: Hypertensive kidney disease is a major cause of morbidity and mortality. Its pattern displays geographical and ethnic variations. Data on these patterns are important for informing management and prevention strategies, but on Kenyans such data are scarce. OBJECTIVE: By means of a retrospective study at Kenyatta National Hospital, Nairobi, we aimed to describe the pattern of hypertensive kidney disease in a black Kenyan population. METHODS: Records of hypertensive patients who had impaired kidney function between January 2000 and December 2010 were examined for mode of diagnosis, age, gender, comorbid factors, treatment and outcome. Data were analyzed using the Statistical Package for Social Sciences, version 16.0 for Windows, and are presented using tables and bar charts. RESULTS: A total of 114 cases (72 males, 42 females) were analyzed. The mean age was 42.7 years (range 12-83), peaking at 51-70 years. The male to female ratio was 1.7:1. Comorbid factors included left ventricular hypertrophy (21.1%), congestive heart failure (15.8%), alcohol (11.4%), cerebrovascular accidents, smoking and retinopathy (10.5% each). Multiple comorbid factors were present in 8.8% of the cases. The majority (52.6%) of the patients survived on hemodialysis, 8.8% underwent successful renal transplant and 22.8% died. CONCLUSION: Hypertensive kidney disease affects all age groups, males more than females. It is commonly associated with other cardiovascular conditions and carries a high morbidity. Vigilant control of blood pressure is recommended.


Assuntos
População Negra/etnologia , Hipertensão Renal/etnologia , Falência Renal Crônica/etnologia , Adolescente , Adulto , Distribuição por Idade , Idade de Início , Idoso , Idoso de 80 Anos ou mais , Anti-Hipertensivos/uso terapêutico , Doenças Cardiovasculares/complicações , Doenças Cardiovasculares/etnologia , Criança , Comorbidade , Feminino , Humanos , Hipertensão Renal/complicações , Hipertensão Renal/tratamento farmacológico , Quênia/epidemiologia , Falência Renal Crônica/complicações , Masculino , Pessoa de Meia-Idade , Características de Residência , Estudos Retrospectivos , Distribuição por Sexo , Fumar/etnologia , Adulto Jovem
19.
Invest Ophthalmol Vis Sci ; 52(8): 5905-9, 2011 Jul 29.
Artigo em Inglês | MEDLINE | ID: mdl-21693603

RESUMO

PURPOSE: To estimate the long-term cumulative incidence and risk factors for retinal vein occlusion (RVO) in a population-based cohort study of Japanese. METHODS: In 1998, a total of 1775 individuals aged 40 years or older underwent a baseline eye examination. Of those, 1369 subjects (77.1%) took part in the follow-up eye examination in 2007 and were enrolled in the present study. Each participant underwent a comprehensive examination. The diagnosis of RVO, including branch (BRVO) and central RVO (CRVO), was determined by grading color fundus photographs. Logistic regression analysis was performed to determine risk factors for RVO. RESULTS: The 9-year cumulative incidence of RVO was 3.0% (2.7% for BRVO and 0.3% for CRVO). The age-specific cumulative incidence of RVO significantly increased with age (P for trend = 0.03). After adjusting for age and sex, higher diastolic blood pressure and chronic kidney disease (CKD) were significantly associated with RVO. In multivariate analysis, higher diastolic blood pressure (per 10 mm Hg) (odds ratio [OR], 1.51; 95% confidence interval [CI], 1.14 to 2.01) and CKD (OR, 2.23; 95% CI, 1.02 to 4.89) remained independently significant risk factors for RVO. In stratified analysis, the risk of RVO was higher in subjects with CKD than that in subjects without CKD in both the nonhypertension and the hypertension groups. CONCLUSIONS: These findings suggest that the incidence of RVO is higher in Japanese than that in other Asians and Caucasians, and that higher blood pressure and CKD are independent risk factors for RVO in the Japanese.


Assuntos
Povo Asiático/estatística & dados numéricos , Hipertensão Renal/etnologia , Oclusão da Veia Retiniana/etnologia , Adulto , Distribuição por Idade , Idoso , Amidoidrolases/sangue , Estudos de Coortes , Feminino , Taxa de Filtração Glomerular , Humanos , Hipertensão Renal/fisiopatologia , Incidência , Japão/epidemiologia , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Modelos Biológicos , Proteinúria/etnologia , Proteinúria/fisiopatologia , Fatores de Risco , Distribuição por Sexo
20.
Cardiol Clin ; 28(4): 623-38, 2010 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-20937446

RESUMO

The benefits of appropriate blood pressure (BP) control include reductions in proteinuria and possibly a slowing of the progressive loss of kidney function. Overall, medication therapy to lower BP during pregnancy should be used mainly for maternal safety because of the lack of data to support an improvement in fetal outcome. The major goal of hypertension treatment in those with baroreceptor dysfunction is to avoid the precipitous, severe BP elevations that characteristically occur during emotional stimulation. The treatment of hypertension in African Americans optimally consists of comprehensive lifestyle modifications along with pharmacologic treatments, most often with combination, not single-drug, therapy.


Assuntos
Anti-Hipertensivos/uso terapêutico , Doenças do Sistema Nervoso Autônomo/tratamento farmacológico , Doenças do Sistema Nervoso Autônomo/etnologia , Barorreflexo/fisiologia , Negro ou Afro-Americano , Hipertensão Induzida pela Gravidez/tratamento farmacológico , Hipertensão Induzida pela Gravidez/etnologia , Hipertensão Renal/tratamento farmacológico , Hipertensão Renal/etnologia , Transplante de Rim , Complicações Pós-Operatórias/tratamento farmacológico , Complicações Pós-Operatórias/etnologia , Anti-Hipertensivos/efeitos adversos , Doenças do Sistema Nervoso Autônomo/etiologia , Doenças do Sistema Nervoso Autônomo/fisiopatologia , Barorreflexo/efeitos dos fármacos , Monitorização Ambulatorial da Pressão Arterial , Terapia Combinada , Comorbidade , Feminino , Humanos , Hipertensão Induzida pela Gravidez/etiologia , Hipertensão Induzida pela Gravidez/fisiopatologia , Hipertensão Renal/etiologia , Hipertensão Renal/fisiopatologia , Transplante de Rim/fisiologia , Masculino , Complicações Pós-Operatórias/etiologia , Complicações Pós-Operatórias/fisiopatologia , Gravidez , Ensaios Clínicos Controlados Aleatórios como Assunto , Fatores de Risco
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...